Clinical Trial Update: Clinical and Microbial Efficacy of ISV403 in Bacterial Conjunctivitis [Phase 2]

View source ↗

Summary

Phase 2 trial evaluated the clinical and microbial efficacy of ISV403 in bacterial conjunctivitis. The study is completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacterial Conjunctivitis

Drugs mentioned

• ISV403

Snippet

Sponsor: Bausch & Lomb Incorporated | Conditions: Bacterial Conjunctivitis | Phase 2 | Status: COMPLETED | Results posted: 2009-08-13